Expand WVE Menu
WVE MENU

WVE Latest Press Releases

-- December 9, 2025 --

Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants Globe Newswire 9:50 PM

-- December 8, 2025 --

Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants Globe Newswire 4:01 PM
Turnarounds and 18,000% Growth Globe Newswire 9:43 AM
Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss Globe Newswire 7:30 AM

-- December 7, 2025 --

Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025 Globe Newswire 4:00 PM

-- November 10, 2025 --

Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update Globe Newswire 7:30 AM

-- November 7, 2025 --

Wave Life Sciences to Present at Upcoming Investor Conferences Globe Newswire 8:30 AM

-- November 4, 2025 --

Wave Life Sciences to Present Preclinical Data Supporting Therapeutic Potential of WVE-007 for Obesity at ObesityWeek 2025 Globe Newswire 8:30 PM
Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025 Globe Newswire 8:30 AM

-- October 29, 2025 --

Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day Globe Newswire 10:50 PM
Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day Globe Newswire 4:15 PM

-- September 18, 2025 --

Wave Life Sciences Announces Virtual Research Day on October 29th and Participation at Upcoming Investor Conferences Globe Newswire 8:30 AM

-- September 3, 2025 --

Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency Globe Newswire 7:30 AM

-- August 6, 2025 --

XtalPi and DoveTree Announce Landmark $6 Billion AI Drug Discovery Collaboration PRNewswire 7:57 PM

-- July 30, 2025 --

Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update Globe Newswire 7:30 AM

-- July 23, 2025 --

Wave Life Sciences Second Quarter 2025 Financial Results Scheduled for July 30, 2025 Globe Newswire 8:30 AM
Market Data Delayed 15 Minutes